SCHEMBL16250484

SCHEMBL16250484

COC(=O)c1cc(O)c(OCc2ccccc2)c(O)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 1.00
HPGD P15428 1/20 1.00
TSHR P16473 2/20 0.52
USP2 O75604 1/20 0.52
ALDH1A1 P00352 1/20 0.52
HSD17B10 Q99714 1/20 0.52
XDH P47989 2/20 0.51
KDM4E B2RXH2 1/20 0.51
POLB P06746 1/20 0.51
GAA P10253 1/20 0.51
NFKB1 P19838 1/20 0.51
GFER P55789 1/20 0.51
NFKB2 Q00653 1/20 0.51
RELA Q04206 1/20 0.51
FUT7 Q11130 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
SMN1; SMN2 Q16637 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24983425 0.91 HPGD (0.84) LMNAHPGDTSHRUSP2ALDH1A1
SCHEMBL30892445 0.91 HPGD (0.84) LMNAHPGDTSHRUSP2ALDH1A1
SCHEMBL1458077 0.90 LMNA (0.82) LMNAHPGDTSHRUSP2ALDH1A1
SCHEMBL18397048 0.90 HPGD (0.82) LMNAHPGDTSHRALDH1A1KDM4E
SCHEMBL22136381 0.90 LMNA (0.82) LMNAHPGDTSHRUSP2ALDH1A1
SCHEMBL22015355 0.88 LMNA (0.78) LMNAHPGDALDH1A1TDP1L3MBTL1
SCHEMBL21738207 0.87 HPGD (0.77) LMNAHPGDALDH1A1KDM4EMEN1
SCHEMBL4874871 0.87 LMNA (0.76) LMNAHPGDXDHKDM4EPOLB
SCHEMBL30102539 0.87 LMNA (0.76) LMNAHPGDXDHKDM4EPOLB
SCHEMBL2338199 0.86 HPGD (0.76) LMNAHPGDTSHRUSP2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119233964-A Single component delivery system for nucleic acids 宾夕法尼亚大学理事会 2024-12-31 CN disclosed
US-20240252677-A1 ONE-COMPONENT DELIVERY SYSTEM FOR NUCLEIC ACIDS THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 2024-08-01 US disclosed
EP-4347550-A1 ONE-COMPONENT DELIVERY SYSTEM FOR NUCLEIC ACIDS The Trustees of the University of Pennsylvania (US) 2024-04-10 EP disclosed
WO-2023198812-A1 COMPOSITIONS OF DISPERSED SYSTEMS FOR BIOMEDICAL APPLICATIONS, PROCESS FOR THEIR PREPARATION AND USES THEREOF SUPERBRANCHE (FR) 2023-10-19 WO disclosed
WO-2023198813-A1 DENDRITIC MOLECULES, PROCESS FOR THEIR PREPARATION AND USES THEREOF SUPERBRANCHE (FR) 2023-10-19 WO disclosed
EP-4261244-A1 DENDRITIC MOLECULES, PROCESS FOR THEIR PREPARATION AND USES THEREOF Superbranche (FR) 2023-10-18 EP disclosed
EP-4260876-A1 COMPOSITIONS OF DISPERSED SYSTEMS FOR BIOMEDICAL APPLICATIONS, PROCESS FOR THEIR PREPARATION AND USES THEREOF Superbranche (FR) 2023-10-18 EP disclosed
WO-2022251191-A1 ONE-COMPONENT DELIVERY SYSTEM FOR NUCLEIC ACIDS THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2022-12-01 WO disclosed
CN-109970765-B Antitumor compound 中国科学院化学研究所 2020-08-11 CN disclosed
US-20160221992-A1 DENDRITIC COMPOUNDS INCLUDING A CHELATING, FLUOROCHROME OR RECOGNITION AGENT, COMPOSITIONS INCLUDING SAME AND USES THEREOF CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS (FR) 2016-08-04 US disclosed
US-20160221992-A1 DENDRITIC COMPOUNDS INCLUDING A CHELATING, FLUOROCHROME OR RECOGNITION AGENT, COMPOSITIONS INCLUDING SAME AND USES THEREOF CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS (FR) 2016-08-04 US disclosed
US-9403944-B2 Antipathogenic guanidinium copolymer LOMBARDI JOHN L (US) 2016-08-02 US disclosed
US-20150011716-A1 Antipathogenic Guanidinium Copolymer LOMBARDI JOHN L (US) 2015-01-08 US disclosed
WO-2014184503-A1 DENDRITIC COMPOUNDS INCLUDING A CHELATING, FLUOROCHROME OR RECOGNITION AGENT, COMPOSITIONS INCLUDING SAME AND USES THEREOF UNIVERSITE DE STRASBOURG (FR) 2014-11-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160221992-A1 DENDRITIC COMPOUNDS INCLUDING A CHELATING, FLUOROCHROME OR RECOGNITION AGENT, COMPOSITIONS INCLUDING SAME AND USES THEREOF MSR1, CD74, CD4 LMNA 2564/4885HPGD 3144/4885TSHR 1795/4885
US-20240252677-A1 ONE-COMPONENT DELIVERY SYSTEM FOR NUCLEIC ACIDS TLR3, TLR9, ADAR LMNA 2652/4885HPGD 4615/4885TSHR 2174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.